FDA Warning Letter — MiMedx Group, Inc.

Case 662942 — FEI 3009814715

The FDA took a Warning Letter action against MiMedx Group, Inc. on December 20, 2023 (Kennesaw, GA). The action was issued by CBER and concerns biologics products. This facility has 3 recent FDA inspections on record.

Action Details

Facility
MiMedx Group, Inc.
Date
December 20, 2023
Fiscal Year
2024
Product Type
Biologics
Center
CBER
Location
Kennesaw, GA (United States)